T. Rowe Price Investment Management
EHC icon

T. Rowe Price Investment Management’s Encompass Health EHC Stock Holding History

T. Rowe Price Investment Management’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.37M Sell
92,674
-3,135,352
-97% -$325M 0.01% 621
2026
Q1 		$312M Buy
3,228,026
+505,139
+19% +$51.8M 0.22% 114
2025
Q4 		$289M Buy
2,722,887
+581,812
+27% +$67.4M 0.18% 131
2025
Q3 		$272M Sell
2,141,075
-34,673
-2% -$4.13M 0.17% 140
2025
Q2 		$267M Buy
2,175,748
+94,830
+5% +$10.8M 0.17% 144
2025
Q1 		$211M Buy
2,080,918
+424,691
+26% +$41.5M 0.14% 165
2024
Q4 		$153M Buy
+1,656,227
New +$163M 0.09% 217

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

T. Rowe Price Investment Management's EHC Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Encompass Health (EHC) stake by 97% in Q2 2026, selling an estimated $325M and leaving 92,674 shares worth $9.37M. The position accounts for 0.01% of the portfolio, ranked #621.

T. Rowe Price Investment Management first reported a position in EHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $312M in Q1 2026. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • T. Rowe Price Investment Management held 92,674 shares of Encompass Health worth $9.37M as of Q2 2026.
  • T. Rowe Price Investment Management sold 3,135,352 Encompass Health shares in Q2 2026, an estimated $325M.
  • Encompass Health made up 0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #621 holding.
  • T. Rowe Price Investment Management first reported a position in Encompass Health in Q4 2024 and has held it in 7 quarters since.
  • T. Rowe Price Investment Management's Encompass Health position peaked at $312M in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.